Join the 200th Anniversary Celebration

Original Article

Beneficial Effects of High Dietary Fiber Intake in Patients with Type 2 Diabetes Mellitus

Manisha Chandalia, M.D., Abhimanyu Garg, M.D., Dieter Lutjohann, Ph.D., Klaus von Bergmann, M.D., Scott M. Grundy, M.D., Ph.D., and Linda J. Brinkley, R.D.

N Engl J Med 2000; 342:1392-1398May 11, 2000

Abstract

Background

The effect of increasing the intake of dietary fiber on glycemic control in patients with type 2 diabetes mellitus is controversial.

Methods

In a randomized, crossover study, we assigned 13 patients with type 2 diabetes mellitus to follow two diets, each for six weeks: a diet containing moderate amounts of fiber (total, 24 g; 8 g of soluble fiber and 16 g of insoluble fiber), as recommended by the American Diabetes Association (ADA), and a high-fiber diet (total, 50 g; 25 g of soluble fiber and 25 g of insoluble fiber) containing foods not fortified with fiber (unfortified foods). Both diets, prepared in a research kitchen, had the same macronutrient and energy content. We compared the effects of the two diets on glycemic control and plasma lipid concentrations.

Results

Compliance with the diets was excellent. During the sixth week of the high-fiber diet, as compared with the sixth week of the ADA diet, mean daily preprandial plasma glucose concentrations were 13 mg per deciliter (0.7 mmol per liter) lower (95 percent confidence interval, 1 to 24 mg per deciliter [0.1 to 1.3 mmol per liter]; P=0.04) and mean daily urinary glucose excretion was 1.3 g lower (median difference, 0.23 g; 95 percent confidence interval, 0.03 to 1.83; P=0.008). The high-fiber diet also lowered the area under the curve for 24-hour plasma glucose and insulin concentrations, which were measured every two hours, by 10 percent (P=0.02) and 12 percent (P=0.05), respectively. The high-fiber diet reduced plasma total cholesterol concentrations by 6.7 percent (P=0.02), triglyceride concentrations by 10.2 percent (P=0.02), and very-low-density lipoprotein cholesterol concentrations by 12.5 percent (P=0.01).

Conclusions

A high intake of dietary fiber, particularly of the soluble type, above the level recommended by the ADA, improves glycemic control, decreases hyperinsulinemia, and lowers plasma lipid concentrations in patients with type 2 diabetes.

Media in This Article

Figure 1Mean (±SE) 24-Hour Profile of Plasma Glucose Concentrations (Panel A) and Insulin Concentrations (Panel B) during the Last Day of the American Diabetes Association (ADA) Diet and the Last Day of the High-Fiber Diet in 13 Patients with Type 2 Diabetes Mellitus.
Table 1Composition of the Study Diets.
Article

Dietary guidelines for patients with diabetes mellitus were revised by the American Diabetes Association (ADA) earlier this year.1 The ADA recommends that the composition of the diet be individualized on the basis of a nutritional assessment and the outcomes desired. Consistent with the previous recommendations of the ADA,2 the new guidelines advise replacing saturated fat with carbohydrates. However, on the basis of previous studies,3-10 an alternative approach of replacing saturated fat with cis monounsaturated fat was also included in the recommendations.1 This new approach is further supported by epidemiologic studies that have shown the healthful effects of diets rich in cis monounsaturated fat in Mediterranean countries.11,12

Another, less strongly emphasized aspect of Mediterranean diets is the high intake of fruits, vegetables, and grains that are rich sources of dietary fiber.13,14 The ADA recommended a moderate increase in the intake of dietary fiber to 20 to 35 g per day because of the cholesterol-lowering effects of soluble fiber. However, the effects of dietary fiber on glycemic control were considered inconsequential.1 Furthermore, the expert panel of the ADA considered it difficult to achieve a high dietary intake of soluble fiber without consuming foods or supplements fortified with fiber.1 We therefore designed the present study to determine the effects on glycemic control and plasma lipid concentrations of increasing the intake of dietary fiber in patients with type 2 diabetes exclusively through the consumption of foods not fortified with fiber (unfortified foods) to a level beyond that recommended by the ADA. In addition, we studied the effects of such an intervention on the intestinal absorption of cholesterol and the fecal excretion of sterols in an attempt to uncover the mechanisms by which a high-fiber diet lowers plasma cholesterol.

Methods

Patients

We studied 12 men and 1 woman (9 non-Hispanic whites and 4 blacks) with type 2 diabetes at the general clinical research center of the University of Texas Southwestern Medical Center at Dallas. The protocol for the study was approved by the institutional review board of the medical center, and each patient gave written informed consent. In all patients the onset of diabetes was insidious; the disease developed in most of the patients after 40 years of age. Their mean (±SD) age was 61±9 years (range, 45 to 70). Their mean body weight was 93.5±12.7 kg, and the mean body-mass index (the weight in kilograms divided by the square of the height in meters) was 32.3±3.9. Three patients were treated with diet alone, and the other 10 patients were treated with 2.5 to 20 mg of glyburide daily in addition to diet. The dose of glyburide was not changed during the study.

On entry into the study, the patients' plasma cholesterol and triglyceride concentrations after an overnight fast ranged from 151 to 324 mg per deciliter (3.90 to 8.38 mmol per liter) and 67 to 390 mg per deciliter (0.76 to 4.40 mmol per liter), respectively, and their fasting plasma glucose concentrations were less than 200 mg per deciliter (11.1 mmol per liter). Their glycosylated hemoglobin values ranged from 6.0 to 9.8 percent. Two patients had a history of coronary heart disease, but none had recently had a myocardial infarction, unstable angina pectoris, or congestive heart failure. Also, none had thyroid, renal, or hepatic disease. None of the patients were receiving lipid-lowering therapy.

Design of the Study

All the patients were first admitted to the general clinical research center for five days (the base-line period), during which a detailed history was taken, a physical examination was performed, and laboratory tests were performed. After the base-line period, all the patients received both the ADA diet and the high-fiber diet, each diet for a period of six weeks. Six patients received the high-fiber diet first, and the other seven received the ADA diet first. There was a median interval of seven days between the two study periods, during which the patients were instructed to consume an isocaloric diet. During the last week of each dietary period (days 36 to 42), the patients were hospitalized for evaluation.

On weekdays, all the patients ate at least one meal (breakfast, lunch, or dinner) at the general clinical research center. Other meals were supplied in packages so that they could be consumed at home. The dietitian monitored compliance by interviewing the patients. The patients were instructed to bring back any unconsumed food and to maintain a constant level of physical activity throughout the study.

Blood for lipid analyses was drawn, after an overnight fast, daily for two days before the institution of the study diet and daily on days 38 through 42 during both dietary periods. Plasma glucose was measured at 7 and 11 a.m. and at 4 and 8 p.m. each day during the base-line period and on days 38 through 42 of both dietary periods. Glycosylated hemoglobin was measured during the base-line period and at the end of each dietary period. On the last day of each dietary period, blood samples were obtained every two hours for measurements of plasma glucose and insulin. On days 38 through 42, patients collected 24-hour urine specimens for quantitative determination of glucose.

To permit us to determine fecal sterol balance and the percentage of cholesterol absorption, each patient took a capsule containing 30 mg of sitostanol, 3 mg of [26,26,26,27,27,27-2H6]-cholesterol, and 3 mg of [5,6,22,23-2H4]-sitostanol (Medical Isotopes, Pelham, N.H.) three times a day on days 36 through 42. Fecal samples were collected on day 35 or 36 and on the last three days of each dietary period. Fecal samples were frozen within 12 hours after collection and were pooled for analysis of small aliquots.

Diets

The composition of the study diets is shown in Table 1Table 1Composition of the Study Diets.. The composition of the diets was calculated by means of a software program based on the Department of Agriculture Handbook Series 8 (Nutriplanner, Practocare, San Diego, Calif.).15 The content of total as well as soluble and insoluble dietary fiber was estimated according to the data provided in the CRC Handbook of Dietary Fiber in Human Nutrition. 16 Both diets consisted of unfortified foods. The patients were allowed some choices of food items. Both diets provided 15 percent of the total energy as protein, 55 percent as carbohydrate, and 30 percent as fat; saturated, cis monounsaturated, and polyunsaturated fats accounted for 7 percent, 17 percent, and 6 percent of the total energy, respectively.

The high-fiber diet provided 50 g of total fiber per day; soluble and insoluble fiber content provided 25 g each. The ADA diet contained 24 g of total fiber per day, with 8 g as soluble fiber and 16 g as insoluble fiber. Unfortified foods, particularly those rich in soluble fiber, such as cantaloupe, grapefruit, orange, papaya, raisins, lima beans, okra, sweet potato, winter squash, zucchini, granola, oat bran, and oatmeal, were used to achieve high-fiber intake. No fiber supplements were used. Sample menus of both the study diets are shown in Table 2Table 2Sample Menus of the Study Diets.. The individual foods were weighed daily during meal preparation in the research kitchen of the general clinical research center.

Biochemical Analyses

Fasting plasma total cholesterol, lipoprotein cholesterol, and triglycerides were measured according to the procedures of the Lipid Research Clinics.17 Cholesterol and triglycerides were measured enzymatically with the use of kits (Boehringer Mannheim, Indianapolis). Very-low-density lipoproteins (VLDLs) (density, less than 1.006 g per milliliter) were removed by ultracentrifugation, and cholesterol was measured in the VLDL fraction and the infranatant. High-density-lipoprotein (HDL) cholesterol was measured enzymatically after lipoproteins containing apolipoprotein B had been precipitated with heparin–manganese. Cholesterol in the low-density lipoprotein (LDL) fraction was estimated to be the difference between the cholesterol content of the infranatant and that of the HDL fraction.

Plasma and urinary glucose were measured by the glucose oxidase method (Beckman Glucose Analyzer, Beckman Instruments, Fullerton, Calif.). Glycosylated hemoglobin was measured with ion-exchange high-performance liquid chromatography (Bio-Rad Laboratories, Hercules, Calif.). Plasma insulin was measured by radioimmunoassay.18,19

Pooled fecal samples collected within the last week of each dietary period were prepared for analysis of neutral and acidic fecal sterols as described previously.20 Gas–liquid chromatography of neutral and acidic fecal sterols was performed on a gas chromatograph (model HP5890, Hewlett–Packard, Palo Alto, Calif.) equipped with an automatic sample injector. Cholesterol absorption was measured during the same period from fecal samples by gas–liquid chromatography and mass spectrometry.21

Statistical Analysis

To compare the two study periods and to assess the effect of the sequence in which the patients received the high-fiber and ADA diets, we used repeated-measures analysis of variance.22 For skewed data, we used the Wilcoxon signed-rank test to compare the two dietary periods.23

Results

The compliance with both the study diets was excellent, according to interviews with the patients and estimates of the energy content of any leftover foods. Three patients reported consuming extra food on one day during the study, two while eating the high-fiber diet and one the ADA diet. The patients commented about the larger quantities of food in the high-fiber diet, but they consumed all the food given to them. The results are presented irrespective of the order of the diets, because the sequence of the diets had no effect on the results.

During the last week of each study period, the patients in both groups had similar daily energy intakes and body weights and received a similar dose of glyburide (Table 3Table 3Metabolic Variables during the Last Week of the Study Periods (Days 38 through 42).). The mean plasma glucose concentration was lower (by 13 mg per deciliter [0.7 mmol per liter], or 8.9 percent) when patients completed the high-fiber diet than when they completed the ADA diet (P=0.04), and mean daily urinary glucose excretion was 1.3 g lower (P=0.008). Daily plasma glucose concentrations were 10 percent lower with the high-fiber diet than with the ADA diet (values for the area under the curve, 3743±944 vs. 3365± 1003 mg hour per deciliter [207.8±52.4 vs. 186.8± 55.7 mmol hour per liter]; P=0.02), and plasma insulin concentrations were 12 percent lower (values for the area under the curve, 1107±650 vs. 971± 491 μU hour per milliliter [6642±3900 vs. 5826± 2946 pmol hour per liter]; P=0.05) (Figure 1Figure 1Mean (±SE) 24-Hour Profile of Plasma Glucose Concentrations (Panel A) and Insulin Concentrations (Panel B) during the Last Day of the American Diabetes Association (ADA) Diet and the Last Day of the High-Fiber Diet in 13 Patients with Type 2 Diabetes Mellitus.). Glycosylated hemoglobin values were slightly lower after the high-fiber diet (P=0.09).

As compared with the ADA diet, the high-fiber diet resulted in a lower fasting plasma total cholesterol concentration (by 6.7 percent, P=0.02), a lower plasma triglyceride concentration (by 10.2 percent, P=0.02), and a lower plasma VLDL cholesterol concentration (by 12.5 percent, P=0.01) (Table 4Table 4Fasting Plasma Lipid and Lipoprotein Concentrations during the Last Week of the Study Periods (Days 38 through 42).). The fasting plasma LDL cholesterol concentration was 6.3 percent lower with the high-fiber diet (P=0.11). There were no significant differences between the two diets in terms of the fasting plasma HDL cholesterol concentration.

As compared with the ADA diet, the high-fiber diet decreased gastrointestinal absorption of cholesterol by 10 percent (48.5±9.6 vs. 43.7±7.4 percent; 95 percent confidence interval for the decrease, 0.6 to 9.0 percent; P=0.03) and increased fecal acidic sterol excretion by 41 percent (895±301 vs. 1258± 458 mg per day; 95 percent confidence interval for the increase, 137 to 589 mg per day; P=0.005), but did not significantly affect the excretion of neutral sterols (1052±375 vs. 1122±565 mg per day; 95 percent confidence interval for the difference, –194 to 334 mg per day; P=0.60).

Discussion

The intake of dietary fiber among people living in Western countries remains low, and according to the Third National Health and Nutrition Examination Survey (NHANES), it averages 17 g per day in the United States.24 Although patients with diabetes are advised to increase their intake of dietary fiber, in the NHANES study, their average daily intake was found to be only 16 g.24 Why the intake of dietary fiber in patients with diabetes remains low — despite its well-documented effect of lowering plasma cholesterol concentrations — remains unexplained. It is possible that the controversy about whether there are beneficial effects of dietary fiber on glycemic control reduces the enthusiasm of physicians and dietitians for recommending high-fiber diets. The main purpose of our study was to investigate the effects on glycemic control of increasing the intake of dietary fiber. To avoid the confounding effects of concomitant changes in energy and macronutrients, the two study diets were isocaloric and the macronutrient composition of the diets was identical. Furthermore, unfortified foods were used as the source of dietary fiber.

Most important, we found that the high-fiber diet improved glycemic control, as evidenced by decreases in the mean daily preprandial and 24-hour plasma glucose concentrations. Urinary glucose excretion was also lowered by the high-fiber diet. The high-fiber diet lowered glycosylated hemoglobin values slightly but not significantly. The high-fiber diet also lowered 24-hour plasma insulin concentrations.

The results of previous studies that evaluated the role of dietary fiber on glycemic control in patients with type 2 diabetes were inconsistent. In some of the studies, the lack of control for concomitant changes in the intake of macronutrients makes the data difficult to interpret. For example, in the study by Kiehm et al.25 and in that by Simpson et al.,26 the high-fiber diet had a lower fat and higher carbohydrate content than the low-fiber diet. In other studies, the interpretation of the results was confounded by the short duration of the dietary intervention,27-29 the lack of random assignment of the sequence of the high-fiber and low-fiber diets,27,29 and unexplained weight loss during the high-fiber diet.29

Only a few well-controlled studies have evaluated the glycemic effects of increasing the intake of dietary fiber with the use of either preparations of refined concentrated fiber or unfortified food, and the results have been inconsistent.1,30 For example, diets that included 15 to 21 g of guar-gum fiber or oat-bran concentrate per day had no effect on glycemic control31,32 or resulted in only a slight improvement.33,34 In randomized, crossover trials of six weeks' duration in which the intake of dietary fiber was increased by 16 g per 1000 kcal through the consumption of foods prepared in a research kitchen or by 14 g per day through dietary instruction, there was no improvement in glycemic control.35,36 In contrast, increasing dietary fiber by 23 g for three weeks and by 30 g for six weeks resulted in decreased fasting and postprandial plasma glucose concentrations.37,38 We found that an increase in the intake of total dietary fiber, which consisted predominantly of soluble fiber, significantly improved glycemic control and decreased the degree of hyperinsulinemia in patients with type 2 diabetes.

Our study also demonstrates the feasibility of achieving a high intake of dietary soluble fiber by consuming unfortified foods. Our patients accepted the high-fiber diet well and had few side effects; therefore, we recommend that patients with diabetes be encouraged to use unfortified foods instead of less palatable purified-fiber preparations and supplements to increase their intake of dietary fiber.

The mechanisms of the improved glycemic control associated with high fiber intake remain undefined. Whether this effect is due to an increase in soluble fiber, insoluble fiber, or both is unclear. Besides causing increased fecal excretion of bile acids, dietary fiber may cause malabsorption of fat.39 However, in our study, the patients' weight did not change with the high-fiber diet, which suggests that the degree of reduction in the absorption of fat was insignificant. Another possibility is that dietary fiber improves glycemic control by reducing or delaying the absorption of carbohydrates.

As expected, the high-fiber diet reduced plasma total cholesterol concentrations by 6.7 percent, a finding consistent with the results of previous reports of the cholesterol-reducing effects of soluble but not insoluble fiber.40,41 Therefore, the lowering of cholesterol can be attributed primarily to an average increase of 17 g in the intake of soluble fiber. Previous studies in normal subjects have reported no effects of the amount of dietary fiber on plasma triglyceride concentrations.42 In our study, the decrease in plasma triglyceride and VLDL cholesterol concentrations during the high-fiber diet could have been due to the improvement in glycemic control.

The mechanisms of the reduction in plasma cholesterol concentrations induced by the increased dietary fiber intake are controversial, however. The increase in bile-acid excretion probably explains most of the reduction, and the reduction in cholesterol absorption may also have contributed to this finding. Previous studies have also reported a variable increase in bile-acid excretion resulting from the consumption of pectin,39,43 oat bran,44,45 bagasse,46 and diets with a mixture of soluble fiber and insoluble fiber,47 but not psyllium.48 In contrast, Kesaniemi et al.47 reported that a high-fiber diet did not change cholesterol absorption in normal subjects. However, the high-fiber diet they used included 26 g of fiber, and it did not lower plasma cholesterol concentrations.47

In conclusion, an increase in the intake of dietary fiber, predominantly of the soluble type, by patients with type 2 diabetes mellitus improved glycemic control and decreased hyperinsulinemia in addition to the expected lowering of plasma lipid concentrations. Therefore, dietary guidelines for patients with diabetes should emphasize an overall increase in dietary fiber through the consumption of unfortified foods, rather than the use of fiber supplements.

Supported in part by grants (M01-RR00633 and HL-29252) from the National Institutes of Health and by research grants from the Bundesministerium für Bildung, Forschung, Wissenschaft und Technologie (01EC9402) and the Deutsche Forschungsgemeinschaft (BE 1673/1-1).

We are indebted to Angela Osborn, Travis Petricek, and the nursing and dietetic service of the General Clinical Research Center of the University of Texas Southwestern Medical Center, Dallas, for their excellent technical support and to Beverley Adams-Huet, M.S., for statistical analysis.

Source Information

From the Department of Internal Medicine (M.C., A.G., S.M.G., L.J.B.) and the Center for Human Nutrition (A.G., S.M.G.), University of Texas Southwestern Medical Center, Dallas; the Department of Veterans Affairs Medical Center, Dallas (M.C., A.G., S.M.G.); and the Department of Clinical Pharmacology, Rheinische Friedrich-Wilhelms-Universität, Bonn, Germany (D.L., K.B.).

Address reprint requests to Dr. Garg at the Center for Human Nutrition, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390.

References

References

  1. 1

    Nutrition recommendations and principles for people with diabetes mellitus. Diabetes Care 2000;23:S43-S46
    Web of Science | Medline

  2. 2

    American Diabetes Association. Nutritional recommendations and principles for individuals with diabetes mellitus: 1986. Diabetes Care 1987;10:126-132
    Web of Science | Medline

  3. 3

    Garg A, Bonanome A, Grundy SM, Zhang Z-J, Unger RH. Comparison of a high-carbohydrate diet with high-monounsaturated-fat diet in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 1988;319:829-834
    Full Text | Web of Science | Medline

  4. 4

    Rivellese AA, Giacco R, Genovese S, et al. Effects of changing amount of carbohydrate in diet on plasma lipoproteins and apolipoproteins in type II diabetic patients. Diabetes Care 1990;13:446-448
    CrossRef | Web of Science | Medline

  5. 5

    Parillo M, Rivellese AA, Ciardullo AV, et al. A high-monounsaturated-fat/low-carbohydrate diet improves peripheral insulin sensitivity in non-insulin-dependent diabetic patients. Metabolism 1992;41:1373-1378
    CrossRef | Web of Science | Medline

  6. 6

    Rasmussen OW, Thomsen C, Hansen KW, Vesterlund M, Winther E, Hermansen K. Effects on blood pressure, glucose, and lipid levels of a high-monounsaturated fat diet compared with a high-carbohydrate diet in NIDDM subjects. Diabetes Care 1993;16:1565-1571
    CrossRef | Web of Science | Medline

  7. 7

    Campbell LV, Marmot PE, Dyer JA, Borkman M, Storlien LH. The high-monounsaturated fat diet as a practical alternative for NIDDM. Diabetes Care 1994;17:177-182
    CrossRef | Web of Science | Medline

  8. 8

    Lerman-Garber I, Ichazo-Cerro S, Zamora-Gonzalez J, Cardoso-Saldana G, Posadas-Romero C. Effect of a high-monounsaturated fat diet enriched with avocado in NIDDM patients. Diabetes Care 1994;17:311-315
    CrossRef | Web of Science | Medline

  9. 9

    Garg A, Grundy SM, Unger RH. Comparison of effects of high and low carbohydrate diets on plasma lipoproteins and insulin sensitivity in patients with mild NIDDM. Diabetes 1992;41:1278-1285
    CrossRef | Web of Science | Medline

  10. 10

    Garg A, Bantle JP, Henry RR, et al. Effects of varying carbohydrate content of diet in patients with non-insulin-dependent diabetes mellitus. JAMA 1994;271:1421-1428
    CrossRef | Web of Science | Medline

  11. 11

    Keys A, Menotti A, Karvonen MJ, et al. The diet and 15-year death rate in the Seven Countries Study. Am J Epidemiol 1986;124:903-915
    Web of Science | Medline

  12. 12

    Menotti A, Keys A, Aravanis C, et al. Seven Countries Study: first 20-year mortality data in 12 cohorts of six countries. Ann Med 1989;21:175-179
    CrossRef | Web of Science | Medline

  13. 13

    Nestle M. Mediterranean diets: historical and research overview. Am J Clin Nutr 1995;61:Suppl:1313S-1320S
    Web of Science | Medline

  14. 14

    Kromhout D, Keys A, Aravanis C, et al. Food consumption patterns in the 1960s in seven countries. Am J Clin Nutr 1989;49:889-894
    Web of Science | Medline

  15. 15

    Department of Agriculture, Agricultural Research Service. Composition of foods. Agriculture handbook No. 8. Series 8-1 to 8-16. Washington, D.C.: Government Printing Office, 1976-1987.

  16. 16

    Schakel S, Sievert YA, Buzzard IM. Dietary fiber values for common foods. In: Spiller GA, ed. CRC handbook of dietary fiber in human nutrition. 2nd ed. Boca Raton, Fla.: CRC Press, 1993:567-93.

  17. 17

    Public Health Service. Manual of laboratory operations: lipid research clinics program: lipid and lipoprotein analysis. 2nd ed. Washington, D.C.: Government Printing Office, 1982.

  18. 18

    Herbert V, Lau KS, Gottlieb CW, Bleicher SJ. Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab 1965;25:1375-1384
    CrossRef | Web of Science | Medline

  19. 19

    Yalow RS, Berson SA. Immunoassay of endogenous plasma insulin in man. J Clin Invest 1960;39:1157-1175
    CrossRef | Web of Science | Medline

  20. 20

    Czubayko F, Beumers B, Lammsfuss S, Lutjohann D, von Bergmann K. A simplified micro-method for quantification of fecal excretion of neutral and acidic sterols for outpatient studies in humans. J Lipid Res 1991;32:1861-1867
    Web of Science | Medline

  21. 21

    Lutjohann D, Meese CO, Crouse JR III, von Bergmann K. Evaluation of deuterated cholesterol and deuterated sitostanol for measurement of cholesterol absorption in humans. J Lipid Res 1993;34:1039-1046
    Web of Science | Medline

  22. 22

    Jones B, Kenward MG. Design and analysis of crossover trials. London: Chapman & Hall, 1989.

  23. 23

    Conover WJ. Practical nonparametric statistics. 2nd ed. New York: John Wiley, 1980:288-92.

  24. 24

    National Health and Nutrition Examination Survey III, 1988-94. NCHS CD-ROM series 11. No. 2A. ASCII version. Hyattsville, Md.: National Center for Health Statistics, April 1998.

  25. 25

    Kiehm TG, Anderson JW, Ward K. Beneficial effects of a high carbohydrate, high fiber diet on hyperglycemic diabetic men. Am J Clin Nutr 1976;29:895-899
    Web of Science | Medline

  26. 26

    Simpson HCR, Simpson RW, Lousley S, et al. A high carbohydrate leguminous fibre diet improves all aspects of diabetic control. Lancet 1981;1:1-5
    CrossRef | Web of Science | Medline

  27. 27

    Rivellese A, Riccardi G, Giacco A, et al. Effect of dietary fibre on glucose control and serum lipoproteins in diabetic patients. Lancet 1980;2:447-450
    CrossRef | Web of Science | Medline

  28. 28

    Riccardi G, Rivellese A, Pacioni D, Genovese S, Mastranzo P, Mancini M. Separate influence of dietary carbohydrate and fibre on the metabolic control in diabetes. Diabetologia 1984;26:116-121
    CrossRef | Web of Science | Medline

  29. 29

    O'Dea K, Traianedes K, Ireland P, et al. The effects of diet differing in fat, carbohydrate, and fiber on carbohydrate and lipid metabolism in type II diabetes. J Am Diet Assoc 1989;89:1076-1086
    Web of Science | Medline

  30. 30

    Nuttall FQ. Dietary fiber in the management of diabetes. Diabetes 1993;42:503-508
    CrossRef | Web of Science | Medline

  31. 31

    Holman RR, Steemson J, Darling P, Turner RC. No glycemic benefit from guar administration in NIDDM. Diabetes Care 1987;10:68-71
    CrossRef | Web of Science | Medline

  32. 32

    Uusitupa M, Siitonen O, Savolainen K, Silvasti M, Penttila I, Parviainen M. Metabolic and nutritional effects of long-term use of guar gum in the treatment of noninsulin-dependent diabetes of poor metabolic control. Am J Clin Nutr 1989;49:345-351
    Web of Science | Medline

  33. 33

    Aro A, Uusitupa M, Voutilainen E, Hersio K, Korhonen T, Siitonen O. Improved diabetic control and hypocholesterolaemic effect induced by long-term dietary supplementation with guar gum in type 2 (insulin-independent) diabetes. Diabetologia 1981;21:29-33
    Web of Science | Medline

  34. 34

    Pick ME, Hawrysh ZJ, Gee MI, Toth E, Garg ML, Hardin RT. Oat bran concentrate bread products improve long-term control of diabetes: a pilot study. J Am Diet Assoc 1996;96:1254-1261
    CrossRef | Web of Science | Medline

  35. 35

    Hollenbeck CB, Coulston AM, Reaven GM. To what extent does increased dietary fiber improve glucose and lipid metabolism in patients with noninsulin-dependent diabetes mellitus (NIDDM)? Am J Clin Nutr 1986;43:16-24
    Web of Science | Medline

  36. 36

    Manhire A, Henry CL, Hartog M, Heaton KW. Unrefined carbohydrate and dietary fibre in treatment of diabetes mellitus. J Hum Nutr 1981;35:99-101
    Medline

  37. 37

    Karlstrom B, Vessby B, Asp NG, et al. Effects of an increased content of cereal fibre in the diet of type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1984;26:272-277
    CrossRef | Web of Science | Medline

  38. 38

    Hagander B, Asp NG, Efendic S, Nilsson-Ehle P, Schersten B. Dietary fiber decreases fasting blood glucose levels and plasma LDL concentration in noninsulin-dependent diabetes mellitus patients. Am J Clin Nutr 1988;47:852-858
    Web of Science | Medline

  39. 39

    Kay RM, Truswell AS. Effect of citrus pectin on blood lipids and fecal steroid excretion in man. Am J Clin Nutr 1977;30:171-175
    Web of Science | Medline

  40. 40

    Jenkins DJ, Newton C, Leeds AR, Cummings JH. Effect of pectin, guar gum, and wheat fibre on serum-cholesterol. Lancet 1975;1:1116-1117
    CrossRef | Web of Science | Medline

  41. 41

    Hillman LC, Peters SG, Fisher CA, Pomare EW. The effects of the fiber components pectin, cellulose and lignin on serum cholesterol levels. Am J Clin Nutr 1985;42:207-213
    Web of Science | Medline

  42. 42

    Brown L, Rosner B, Willett WW, Sacks FM. Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr 1999;69:30-42
    Web of Science | Medline

  43. 43

    Cummings JH, Southgate DAT, Branch WJ, et al. The digestion of pectin in the human gut and its effect on calcium absorption and large bowel function. Br J Nutr 1979;41:477-485
    CrossRef | Web of Science | Medline

  44. 44

    Kirby RW, Anderson JW, Sieling B, et al. Oat-bran intake selectively lowers serum low-density lipoprotein cholesterol concentrations of hypercholesterolemic men. Am J Clin Nutr 1981;34:824-829
    Web of Science | Medline

  45. 45

    Zhang JX, Hallmans G, Andersson H, et al. Effect of oat bran on plasma cholesterol and bile acid excretion in nine subjects with ileostomies. Am J Clin Nutr 1992;56:99-105
    Web of Science | Medline

  46. 46

    Walters RL, Baird IM, Davies PS, et al. Effects of two types of dietary fibre on faecal steroid and lipid excretion. BMJ 1975;2:536-538
    CrossRef | Web of Science | Medline

  47. 47

    Kesaniemi YA, Tarpila S, Miettinen TA. Low vs high dietary fiber and serum, biliary, and fecal lipids in middle-aged men. Am J Clin Nutr 1990;51:1007-1012
    Web of Science | Medline

  48. 48

    Abraham ZD, Mehta T. Three-week psyllium-husk supplementation: effect on plasma cholesterol concentrations, fecal steroid excretion, and carbohydrate absorption in men. Am J Clin Nutr 1988;47:67-74
    Web of Science | Medline

Citing Articles (181)

Citing Articles

  1. 1

    D. Aune, D. S. M. Chan, D. C. Greenwood, A. R. Vieira, D. A. N. Rosenblatt, R. Vieira, T. Norat. (2012) Dietary fiber and breast cancer risk: a systematic review and meta-analysis of prospective studies. Annals of Oncology
    CrossRef

  2. 2

    Elliot M Berry, Yardena Arnoni, Michael Aviram. (2011) The Middle Eastern and biblical origins of the Mediterranean diet. Public Health Nutrition 14:12A, 2288-2295
    CrossRef

  3. 3

    Alfredo C. Cordova, Brandon J. Sumpio, Bauer E. Sumpio. (2011) Perfecting the Plate: Adding Cardioprotective Compounds to the Diet. Journal of the American College of Surgeons
    CrossRef

  4. 4

    Christian Clement Yde, Johan A. Westerhuis, Hanne Christine Bertram, Knud Erik Bach Knudsen. (2011) Application of NMR-based metabonomics suggests a relationship between betaine absorption and elevated creatine plasma concentrations in catheterised sows. British Journal of Nutrition1-13
    CrossRef

  5. 5

    Federica Intorre, L. M. Donini, G. Catasta, B. Neri, T. Hagedorn, E. Toti, M. S. Foddai, E. Venneria, L. Palomba, E. Azzini, L. Rossi, A. Pinto, A. M. Giusti, G. Maiani. (2011) Effect of acute consumption of strawberry jam on glycaemic status in both non-complicated and type 2 diabetic obese volunteers: a pilot study. Mediterranean Journal of Nutrition and Metabolism
    CrossRef

  6. 6

    J. Salas-Salvadó, M.Á. Martinez-González, M. Bulló, E. Ros. (2011) The role of diet in the prevention of type 2 diabetes. Nutrition, Metabolism and Cardiovascular Diseases 21, B32-B48
    CrossRef

  7. 7

    K.R. Juvonen, M. Salmenkallio-Marttila, M. Lyly, K.-H. Liukkonen, L. Lähteenmäki, D.E. Laaksonen, M.I. Uusitupa, K.H. Herzig, K.S. Poutanen, L.J. Karhunen. (2011) Semisolid meal enriched in oat bran decreases plasma glucose and insulin levels, but does not change gastrointestinal peptide responses or short-term appetite in healthy subjects. Nutrition, Metabolism and Cardiovascular Diseases 21:9, 748-756
    CrossRef

  8. 8

    Lisa Te Morenga, Jim Mann. 2011. Nutrition: Its Relevance in Development and Treatment of the Metabolic Syndrome. , 297-326.
    CrossRef

  9. 9

    Anjali A Dixit, Kristen MJ Azar, Christopher D Gardner, Latha P Palaniappan. (2011) Incorporation of whole, ancient grains into a modern Asian Indian diet to reduce the burden of chronic disease. Nutrition Reviews 69:8, 479-488
    CrossRef

  10. 10

    Yi Lin, Inge Huybrechts, Stefanie Vandevijvere, Selin Bolca, Willem De Keyzer, Stephanie De Vriese, Anja Polet, Melissa De Neve, Herman Van Oyen, John Van Camp, Guy De Backer, Stefaan De Henauw. (2011) Fibre intake among the Belgian population by sex–age and sex–education groups and its association with BMI and waist circumference. British Journal of Nutrition 105:11, 1692-1703
    CrossRef

  11. 11

    A. Prathapan, K. Fahad, Bins K. Thomas, Riya Mariam Philip, K. G. Raghu. (2011) Effect of sprouting on antioxidant and inhibitory potential of two varieties of Bengal gram ( Cicer arietinum L .) against key enzymes linked to type-2 diabetes. International Journal of Food Sciences and Nutrition 62:3, 234-238
    CrossRef

  12. 12

    H. Kahleova, M. Matoulek, H. Malinska, O. Oliyarnik, L. Kazdova, T. Neskudla, A. Skoch, M. Hajek, M. Hill, M. Kahle, T. Pelikanova. (2011) Vegetarian diet improves insulin resistance and oxidative stress markers more than conventional diet in subjects with Type 2 diabetes. Diabetic Medicine 28:5, 549-559
    CrossRef

  13. 13

    H. A. Al-Amiri, N. M. Al-Hamad, F. A. Al-Awadhi, M. Y. Al-Foudari, J. A. Al-Otaibi, A. H. Binheji. (2011) Total, insoluble and soluble dietary fiber contents of selected Kuwaiti composite dishes. International Journal of Food Sciences and Nutrition 62:2, 152-157
    CrossRef

  14. 14

    Nana K.A. BONSU, C. Shanthi JOHNSON, Katherine M. MCLEOD. (2011) Can dietary fructans lower serum glucose?. Journal of Diabetes 3:1, 58-66
    CrossRef

  15. 15

    Sebely Pal, Alireza Khossousi, Colin Binns, Satvinder Dhaliwal, Vanessa Ellis. (2011) The effect of a fibre supplement compared to a healthy diet on body composition, lipids, glucose, insulin and other metabolic syndrome risk factors in overweight and obese individuals. British Journal of Nutrition 105:01, 90-100
    CrossRef

  16. 16

    Taylor Wolfram, Faramarz Ismail-Beigi. (2011) Efficacy of High-Fiber Diets in The Management of Type 2 Diabetes Mellitus. Endocrine Practice 17:1, 132-142
    CrossRef

  17. 17

    Jessica Chang, Christopher K Rayner, Karen L Jones, Michael Horowitz. (2011) Diabetic gastroparesis-Backwards and forwards. Journal of Gastroenterology and Hepatology 26, 46-57
    CrossRef

  18. 18

    Inmaculada Mateos-Aparicio, Araceli Redondo-Cuenca, María-José Villanueva-Suárez. (2011) Broad bean and pea by-products as sources of fibre-rich ingredients: potential antioxidant activity measured in vitro. Journal of the Science of Food and Agriculturen/a-n/a
    CrossRef

  19. 19

    Jessica Chang, Christopher K. Rayner, Karen L. Jones, Michael Horowitz. (2010) Diabetic Gastroparesis and Its Impact on Glycemia. Endocrinology & Metabolism Clinics of North America 39:4, 745-762
    CrossRef

  20. 20

    Marion J. Franz, Margaret A. Powers, Carolyn Leontos, Lea Ann Holzmeister, Karmeen Kulkarni, Arlene Monk, Naomi Wedel, Erica Gradwell. (2010) The Evidence for Medical Nutrition Therapy for Type 1 and Type 2 Diabetes in Adults. Journal of the American Dietetic Association 110:12, 1852-1889
    CrossRef

  21. 21

    Valeri Mossine, Thomas Mawhinney. 2010. Significance of Processing for the Chemopreventive Potential of Tomato-Based Products. , 279-300.
    CrossRef

  22. 22

    L Te Morenga, S Williams, R Brown, J Mann. (2010) Effect of a relatively high-protein, high-fiber diet on body composition and metabolic risk factors in overweight women. European Journal of Clinical Nutrition 64:11, 1323-1331
    CrossRef

  23. 23

    Yearul Kabir, Jiwan Sidhu. 2010. Antioxidant Functional Factors in Nuts. , 343-397.
    CrossRef

  24. 24

    Monica Sørensen, Odd E. Johansen. (2010) Idiopathic reactive hypoglycaemia – Prevalence and effect of fibre on glucose excursions. Scandinavian Journal of Clinical & Laboratory Investigation 70:6, 385-391
    CrossRef

  25. 25

    Miguel Angel Larrea Céspedes, Fernando Martínez Bustos, Yoon Kil chang. (2010) The Effect of Extruded Orange Pulp on Enzymatic Hydrolysis of Starch and Glucose Retardation Index. Food and Bioprocess Technology 3:5, 684-692
    CrossRef

  26. 26

    Hans Hauner. 2010. Obesity and Diabetes. , 227-241.
    CrossRef

  27. 27

    Clifford J. Bailey. 2010. Future Drug Treatments for Type 2 Diabetes. , 1017-1044.
    CrossRef

  28. 28

    Monika Toeller. 2010. Lifestyle Issues: Diet. , 346-357.
    CrossRef

  29. 29

    I. Mateos-Aparicio, C. Mateos-Peinado, P. Rupérez. (2010) High hydrostatic pressure improves the functionality of dietary fibre in okara by-product from soybean. Innovative Food Science & Emerging Technologies 11:3, 445-450
    CrossRef

  30. 30

    Mariam Farhad, Kasipathy Kailasapathy, Jyoti Tamang. 2010. Health Aspects of Fermented Foods. , 391-414.
    CrossRef

  31. 31

    Michelle L. Sleeth, Emily L. Thompson, Heather E. Ford, Sagen E. K. Zac-Varghese, Gary Frost. (2010) Free fatty acid receptor 2 and nutrient sensing: a proposed role for fibre, fermentable carbohydrates and short-chain fatty acids in appetite regulation. Nutrition Research Reviews 23:01, 135-145
    CrossRef

  32. 32

    David Sánchez, Leila Moulay, Begoña Muguerza, Mar Quiñones, Marta Miguel, Amaya Aleixandre. (2010) Effect of a Soluble Cocoa Fiber-Enriched Diet in Zucker Fatty Rats. Journal of Medicinal Food 13:3, 621-628
    CrossRef

  33. 33

    Arun Kumar Verma, Rituparna Banerjee. (2010) Dietary fibre as functional ingredient in meat products: a novel approach for healthy living — a review. Journal of Food Science and Technology 47:3, 247-257
    CrossRef

  34. 34

    Baljit Singh, Nirmala Chauhan. (2010) Dietary fiber psyllium based hydrogels for use in insulin delivery. International Journal of Diabetes Mellitus 2:1, 32-37
    CrossRef

  35. 35

    A. Elhayany, A. Lustman, R. Abel, J. Attal-Singer, S. Vinker. (2010) A low carbohydrate Mediterranean diet improves cardiovascular risk factors and diabetes control among overweight patients with type 2 diabetes mellitus: a 1-year prospective randomized intervention study. Diabetes, Obesity and Metabolism 12:3, 204-209
    CrossRef

  36. 36

    Nazanin Noori, Mohsen Nafar, Fatemeh Poorrezagholi, Pedram Ahmadpoor, Fariba Samadian, Ahmad Firouzan, Behzad Einollahi. (2010) Dietary Intakes of Fiber and Magnesium and Incidence of Metabolic Syndrome in First Year After Renal Transplantation. Journal of Renal Nutrition 20:2, 101-111
    CrossRef

  37. 37

    Colleen P. Gobert, Elizabeth A. Pipe, Sarah E. Capes, Gerarda A. Darlington, Johanna W. Lampe, Alison M. Duncan. (2010) Soya protein does not affect glycaemic control in adults with type 2 diabetes. British Journal of Nutrition 103:03, 412
    CrossRef

  38. 38

    Cyril W.C. Kendall, Amin Esfahani, David J.A. Jenkins. (2010) The link between dietary fibre and human health. Food Hydrocolloids 24:1, 42-48
    CrossRef

  39. 39

    Athanasios Papathanasopoulos, Michael Camilleri. (2010) Dietary Fiber Supplements: Effects in Obesity and Metabolic Syndrome and Relationship to Gastrointestinal Functions. Gastroenterology 138:1, 65-72.e2
    CrossRef

  40. 40

    M. Krahl, S. Müller, M. Zarnkow, W. Back, T. Becker. (2009) Arabinoxylan and fructan in the malting and brewing process. Quality Assurance and Safety of Crops & Foods 1:4, 246-255
    CrossRef

  41. 41

    Vladimir Vuksan, Alexander L. Rogovik, Elena Jovanovski, Alexandra L. Jenkins. (2009) Fiber facts: Benefits and recommendations for individuals with type 2 diabetes. Current Diabetes Reports 9:5, 405-411
    CrossRef

  42. 42

    Preecha Phuwapraisirisan, Thanchanok Puksasook, Udom Kokpol, Khanit Suwanborirux. (2009) Corchorusides A and B, new flavonol glycosides as α-glucosidase inhibitors from the leaves of Corchorus olitorius. Tetrahedron Letters 50:42, 5864-5867
    CrossRef

  43. 43

    Jing Ma, Christopher K. Rayner, Karen L. Jones, Michael Horowitz. (2009) Insulin secretion in healthy subjects and patients with Type 2 diabetes – role of the gastrointestinal tract. Best Practice & Research Clinical Endocrinology & Metabolism 23:4, 413-424
    CrossRef

  44. 44

    S C Larsson, S Männistö, M J Virtanen, J Kontto, D Albanes, J Virtamo. (2009) Dietary fiber and fiber-rich food intake in relation to risk of stroke in male smokers. European Journal of Clinical Nutrition 63:8, 1016-1024
    CrossRef

  45. 45

    J. L. Sievenpiper, C. W. C. Kendall, A. Esfahani, J. M. W. Wong, A. J. Carleton, H. Y. Jiang, R. P. Bazinet, E. Vidgen, D. J. A. Jenkins. (2009) Effect of non-oil-seed pulses on glycaemic control: a systematic review and meta-analysis of randomised controlled experimental trials in people with and without diabetes. Diabetologia 52:8, 1479-1495
    CrossRef

  46. 46

    C J North, C S Venter, J C Jerling. (2009) The effects of dietary fibre on C-reactive protein, an inflammation marker predicting cardiovascular disease. European Journal of Clinical Nutrition 63:8, 921-933
    CrossRef

  47. 47

    M. Rodríguez-Morán, F. Guerrero-Romero, R.A. Rascón-Pacheco. (2009) Dietary factors related to the increase of cardiovascular risk factors in traditional Tepehuanos communities from Mexico. A 10 year follow-up study. Nutrition, Metabolism and Cardiovascular Diseases 19:6, 409-416
    CrossRef

  48. 48

    Eun-Jin Park, Deok-Young Jhon. (2009) Effects of bamboo shoot consumption on lipid profiles and bowel function in healthy young women. Nutrition 25:7-8, 723-728
    CrossRef

  49. 49

    Jing Ma, Christopher K. Rayner, Karen L. Jones, Michael Horowitz. (2009) Diabetic Gastroparesis. Drugs 69:8, 971-986
    CrossRef

  50. 50

    Shirin Jahan Mumu, Farzana Saleh, Fadia Afnan, Afroza Akhter, Kazi Rumana Ahm. (2009) Pattern of Dietary Intake among Newly Diagnosed Type 2 Diabetic Subjects with Hypercholesterolemia. Pakistan Journal of Nutrition 8:6, 721-724
    CrossRef

  51. 51

    Neal D Barnard, Heather I Katcher, David JA Jenkins, Joshua Cohen, Gabrielle Turner-McGrievy. (2009) Vegetarian and vegan diets in type 2 diabetes management. Nutrition Reviews 67:5, 255-263
    CrossRef

  52. 52

    S. Liatis, P. Tsapogas, E. Chala, C. Dimosthenopoulos, K. Kyriakopoulos, E. Kapantais, N. Katsilambros. (2009) The consumption of bread enriched with betaglucan reduces LDL-cholesterol and improves insulin resistance in patients with type2 diabetes. Diabetes & Metabolism 35:2, 115-120
    CrossRef

  53. 53

    T Steemburgo, V Dall'Alba, J C Almeida, T Zelmanovitz, J L Gross, M J de Azevedo. (2009) Intake of soluble fibers has a protective role for the presence of metabolic syndrome in patients with type 2 diabetes. European Journal of Clinical Nutrition 63:1, 127-133
    CrossRef

  54. 54

    E. J. M. Feskens. 2009. Nutrition and the metabolic syndrome in the elderly. , 349-373.
    CrossRef

  55. 55

    2009. Dietary Fiber and Dietary Fiber Rich Foods. , 63-111.
    CrossRef

  56. 56

    T. Oyama, S. Fukuda, T. Shimoyama, I. Takahashi, T. Umeda, K. Danjo, D. Saito, D. Chinda, J. Sakamoto, S. Nakaji. (2008) The Oro-Ileal Transit of Cellulose. Journal of Food Science 73:9, H229-H234
    CrossRef

  57. 57

    Amaya Aleixandre, Marta Miguel. (2008) Dietary Fiber in the Prevention and Treatment of Metabolic Syndrome: A Review. Critical Reviews in Food Science and Nutrition 48:10, 905-912
    CrossRef

  58. 58

    (2008) Position of the American Dietetic Association: Health Implications of Dietary Fiber. Journal of the American Dietetic Association 108:10, 1716-1731
    CrossRef

  59. 59

    Jae Young Cha, Yong Taek Kim, Hyeong Soo Kim, Young Su Cho. (2008) Antihyperglycemic Effect of Stem Bark Powder from Paper Mulberry ( Broussonetia kazinoki Sieb.) in Type 2 Diabetic Otsuka Long-Evans Tokushima Fatty Rats. Journal of Medicinal Food 11:3, 499-505
    CrossRef

  60. 60

    Shinichi Watanabe, Katsuya Suemaru, Naoto Inoue, Kimie Imai, Tachio Aimoto, Hiroaki Araki. (2008) Pharmacokinetic and pharmacodynamic studies of drug interaction following oral administration of imipramine and sodium alginate in rats. Naunyn-Schmiedeberg's Archives of Pharmacology 378:1, 85-91
    CrossRef

  61. 61

    Jordi Salas-Salvadó, Xavier Farrés, Xavier Luque, Silvia Narejos, Manel Borrell, Josep Basora, Anna Anguera, Ferran Torres, Mònica Bulló, Rafel Balanza, . (2008) Effect of two doses of a mixture of soluble fibres on body weight and metabolic variables in overweight or obese patients: a randomised trial. British Journal of Nutrition 99:06,
    CrossRef

  62. 62

    Madelyn L. Wheeler, F. Xavier Pi-Sunyer. (2008) Carbohydrate Issues: Type and Amount. Journal of the American Dietetic Association 108:4, S34-S39
    CrossRef

  63. 63

    Judith E. Urías-Silvas, Patrice D. Cani, Evelyne Delmée, Audrey Neyrinck, Mercedes G. López, Nathalie M. Delzenne. (2008) Physiological effects of dietary fructans extracted from Agave tequilana Gto. and Dasylirion spp.. British Journal of Nutrition 99:02,
    CrossRef

  64. 64

    A Flood, V Mai, R Pfeiffer, L Kahle, A T Remaley, C J Rosen, E Lanza, A Schatzkin. (2008) The effects of a high-fruit and -vegetable, high-fiber, low-fat dietary intervention on serum concentrations of insulin, glucose, IGF-I and IGFBP-3. European Journal of Clinical Nutrition 62:2, 186-196
    CrossRef

  65. 65

    Kazunari IWAO, Rushiana Tokie KAWAI, Masako ODA, Michiya KOBAYASHI, Hiroshi SAITOH. (2008) Physicochemical Interactions of Metformin Hydrochloride and Glibenclamide with Several Health Foods. YAKUGAKU ZASSHI 128:9, 1341-1345
    CrossRef

  66. 66

    Richard D. Feinman, Jeff S. Volek. (2008) Carbohydrate restriction as the default treatment for type 2 diabetes and metabolic syndrome. Scandinavian Cardiovascular Journal 42:4, 256-263
    CrossRef

  67. 67

    M. A. Pereira. 2008. Whole grain consumption and insulin sensitivity. , 112-125.
    CrossRef

  68. 68

    Thomas Wolever, Janet Vogt. 2007. The Metabolic Syndrome and Type 2 Diabetes Mellitus. .
    CrossRef

  69. 69

    Zhong Q. Wang, Aamir R. Zuberi, Xian H. Zhang, Jacalyn Macgowan, Jianhua Qin, Xin Ye, Leslie Son, Qinglin Wu, Kun Lian, William T. Cefalu. (2007) Effects of dietary fibers on weight gain, carbohydrate metabolism, and gastric ghrelin gene expression in mice fed a high-fat diet. Metabolism 56:12, 1635-1642
    CrossRef

  70. 70

    Jinesh Kochar, Luc Djoussé, J. Michael Gaziano. (2007) Breakfast Cereals and Risk of Type 2 Diabetes in the Physicians’ Health Study I**. Obesity 15:12, 3039-3044
    CrossRef

  71. 71

    J Mann. (2007) Dietary carbohydrate: relationship to cardiovascular disease and disorders of carbohydrate metabolism. European Journal of Clinical Nutrition 61, S100-S111
    CrossRef

  72. 72

    J H Cummings, A M Stephen. (2007) Carbohydrate terminology and classification. European Journal of Clinical Nutrition 61, S5-S18
    CrossRef

  73. 73

    Paul Kuo, Christopher K. Rayner, Michael Horowitz. (2007) Gastric Emptying, Diabetes, and Aging. Clinics in Geriatric Medicine 23:4, 785-808
    CrossRef

  74. 74

    Kavita Sharma, Swati Dhruv, Uliyar Mani, Indirani Mani, Uma Iyer. 2007. Therapeutic Utility of Spirulina. , 71-99.
    CrossRef

  75. 75

    Masamitsu Hinata, Masami Ono, Sanae Midorikawa, Koji Nakanishi. (2007) Metabolic improvement of male prisoners with type 2 diabetes in Fukushima Prison, Japan. Diabetes Research and Clinical Practice 77:2, 327-332
    CrossRef

  76. 76

    Maciej Turowski, Balasaheb Deshmukh, Robert Harfmann, Jerry Conklin, Stephanie Lynch. (2007) A method for determination of soluble dietary fiber in methylcellulose and hydroxypropyl methylcellulose food gums. Journal of Food Composition and Analysis 20:5, 420-429
    CrossRef

  77. 77

    William J. Kraemer, Jakob L. Vingren, Ricardo Silvestre, Barry A. Spiering, Disa L. Hatfield, Jen Y. Ho, Maren S. Fragala, Carl M. Maresh, Jeff S. Volek. (2007) Effect of adding exercise to a diet containing glucomannan. Metabolism 56:8, 1149-1158
    CrossRef

  78. 78

    Ramprasad Gadi, Frederick F. Samaha. (2007) Dyslipidemia in type 2 diabetes mellitus. Current Diabetes Reports 7:3, 228-234
    CrossRef

  79. 79

    Angela Mazza. 2007. Nutrition and Type 2 Diabetes Mellitus in the Geriatric Patient. , 433-440.
    CrossRef

  80. 80

    D. Maggs, I. MacDonald, M. A. Nauck. (2007) Glucose homeostasis and the gastrointestinal tract: insights into the treatment of diabetes. Diabetes, Obesity and Metabolism 0:0, 070509203705001-???
    CrossRef

  81. 81

    Mahmood Wahed, Michael Geoghegan, Jeremy Powell-Tuck. (2007) Novel substrates. European Journal of Gastroenterology & Hepatology 19:5, 365-370
    CrossRef

  82. 82

    M. Toeller. (2007) Ernährungstherapie bei Diabetes mellitus. Ernährung - Wissenschaft und Praxis 1:3, 116-123
    CrossRef

  83. 83

    M.S. Butt, Aftab Ahmad, M.K. Sharif. (2007) Influence of Pectin and Guar Gum Composite Flour on Plasma Biochemical Profile of Streptozotocin-Induced Diabetic Male Albino Rats. International Journal of Food Properties 10:2, 345-361
    CrossRef

  84. 84

    Sarah AM Kelly, Carolyn D Summerbell, Audrey Brynes, Victoria Whittaker, Gary Frost, Sarah AM Kelly. 2007. Wholegrain cereals for coronary heart disease. .
    CrossRef

  85. 85

    A. Kohl, A.F.H. Pfeiffer. (2007) Primärprävention. Der Diabetologe 3:2, 120-125
    CrossRef

  86. 86

    A L Garcia, B Otto, S-C Reich, M O Weickert, J Steiniger, A Machowetz, N N Rudovich, M Möhlig, N Katz, M Speth, F Meuser, J Doerfer, H-J F Zunft, A H F Pfeiffer, C Koebnick. (2007) Arabinoxylan consumption decreases postprandial serum glucose, serum insulin and plasma total ghrelin response in subjects with impaired glucose tolerance. European Journal of Clinical Nutrition 61:3, 334-341
    CrossRef

  87. 87

    Andrea R. Josse, Cyril W.C. Kendall, Livia S.A. Augustin, Peter R. Ellis, David J.A. Jenkins. (2007) Almonds and postprandial glycemia—a dose-response study. Metabolism 56:3, 400-404
    CrossRef

  88. 88

    S W Rizkalla, M Laromiguiere, M Champ, F Bruzzo, J Boillot, G Slama. (2007) Effect of baking process on postprandial metabolic consequences: randomized trials in normal and type 2 diabetic subjects. European Journal of Clinical Nutrition 61:2, 175-183
    CrossRef

  89. 89

    Jennifer J. Daubenmier, Gerdi Weidner, Michael D. Sumner, Nancy Mendell, Terri Merritt-Worden, Joli Studley, Dean Ornish. (2007) The contribution of changes in diet, exercise, and stress management to changes in coronary risk in women and men in the Multisite Cardiac Lifestyle Intervention Program. Annals of Behavioral Medicine 33:1, 57-68
    CrossRef

  90. 90

    Nobukiyo Koide, Tomokazu Oyama, Yoh Miyashita, Kouji Shirai. (2007) Effects of Calorie-Restricted Low-Carbohydrate Diet on Glucose and Lipid Metabolism in Otsuka Long Evans Tokushima Fatty Rats. Journal of Atherosclerosis and Thrombosis 14:5, 253-260
    CrossRef

  91. 91

    A. Redondo-Cuenca, M.J. Villanueva-Suárez, M.D. Rodríguez-Sevilla, I. Mateos-Aparicio. (2007) Chemical composition and dietary fibre of yellow and green commercial soybeans (Glycine max). Food Chemistry 101:3, 1216-1222
    CrossRef

  92. 92

    Pei-Ying LIN, Bui Thi NHUNG, Nguyen Cong KHAN, Nobuko SARUKURA, Daisuke KUNII, Tohru SAKAI, Afework KASSU, Shigeru YAMAMOTO. (2007) Effect of Vietnamese Common Diet on Postprandial Blood Glucose Level in Adult Females. Journal of Nutritional Science and Vitaminology 53:3, 247-252
    CrossRef

  93. 93

    Yumiko IZUMI, Genji ISHIBASHI, Yumiko NAKANISHI, Shigeshi KIKUNAGA. (2007) Beneficial Effect of 3% Milled-Rice on Blood Glucose Level and Serum Lipid Concentrations in Spontaneously Non-Insulin-Dependent Diabetic Rats. Journal of Nutritional Science and Vitaminology 53:5, 400-409
    CrossRef

  94. 94

    Ronald Goldberg. 2006. Type 2 Diabetes. , 187-254.
    CrossRef

  95. 95

    Judy Giusti, Jo-Anne Rizzotto. (2006) Interpreting the Joslin diabetes center and joslin clinic clinical nutrition guideline for overweight and obese adults with type 2 diabetes. Current Diabetes Reports 6:5, 405-408
    CrossRef

  96. 96

    U Schwab, A Louheranta, A Törrönen, M Uusitupa. (2006) Impact of sugar beet pectin and polydextrose on fasting and postprandial glycemia and fasting concentrations of serum total and lipoprotein lipids in middle-aged subjects with abnormal glucose metabolism. European Journal of Clinical Nutrition 60:9, 1073-1080
    CrossRef

  97. 97

    J.I. Mann. (2006) Nutrition Recommendations for the Treatment and Prevention of Type 2 Diabetes and the Metabolic Syndrome: An Evidenced-Based Review. Nutrition Reviews 64:9, 422-427
    CrossRef

  98. 98

    SANDRA E. KAYS, J.B. MORRIS, YOOKYUNG KIM. (2006) TOTAL AND SOLUBLE DIETARY FIBER VARIATION IN CYAMOPSIS TETRAGONOLOBA (L.) TAUB. (GUAR) GENOTYPES. Journal of Food Quality 29:4, 383-391
    CrossRef

  99. 99

    Nanette Steinle, Nick Gonzalez, M Patricia Fuhrman, Kelly Eiden, Cynthia Payne. 2006. Nutrition and the Pancreas. .
    CrossRef

  100. 100

    M. Toeller. (2006) Ernährungstherapie bei Diabetes. Der Diabetologe 2:3, 215-225
    CrossRef

  101. 101

    Maria P. Solano, Ronald B. Goldberg. (2006) Management of Dyslipidemia in Diabetes. Cardiology in Review 14:3, 125-135
    CrossRef

  102. 102

    A. Kohl, A. F. H. Pfeiffer. (2006) Ernährung bei Diabetes. Der Diabetologe 2:3, 226-232
    CrossRef

  103. 103

    K.W. Lee, K.E. Song, H.S. Lee, Y.K. Kim, S.W. Lee, D.J. Kim, W.S. Hwang, S.J. Choe, Y.S. Kim, T.Y. Kim. (2006) The Effects of Goami No. 2 Rice, a Natural Fiber-Rich Rice, on Body Weight and Lipid Metabolism*. Obesity 14:3, 423-430
    CrossRef

  104. 104

    Aedin Cassidy, Paola Albertazzi, Inge Lise Nielsen, Wendy Hall, Gary Williamson, Inge Tetens, Steve Atkins, Heide Cross, Yannis Manios, Alicja Wolk, Claudia Steiner, Francesco Branca. (2006) Critical review of health effects of soyabean phyto-oestrogens in post-menopausal women. Proceedings of the Nutrition Society 65:01, 76-92
    CrossRef

  105. 105

    Elise Brett. 2006. Nutrition Support and Hyperglycemia. , 171-192.
    CrossRef

  106. 106

    Cathy Nonas, Bantwal Suresh Baliga, Zachary Bloomgarden. 2006. Medical Nutrition Therapy For Patients With Type-2 Diabetes. , 81-104.
    CrossRef

  107. 107

    J. M. A. Hannan, L. Ali, J. Khaleque, M. Akhter, P. R. Flatt, Y. H. A. Abdel-Wahab. (2006) Aqueous extracts of husks of Plantago ovata reduce hyperglycaemia in type 1 and type 2 diabetes by inhibition of intestinal glucose absorption. British Journal of Nutrition 96:01, 131
    CrossRef

  108. 108

    Tricia Psota, Kirsten Hilpert, Sarah Gebauer, Penny Kris-Etherton, Amy Griel, Yumei Coa. 2005. New Insights on the Role of Lipids and Lipoproteins in Cardiovascular Disease. , 211-263.
    CrossRef

  109. 109

    M. O. Weickert, M. Mohlig, C. Koebnick, J. J. Holst, P. Namsolleck, M. Ristow, M. Osterhoff, H. Rochlitz, N. Rudovich, J. Spranger, A. F. H. Pfeiffer. (2005) Impact of cereal fibre on glucose-regulating factors. Diabetologia 48:11, 2343-2353
    CrossRef

  110. 110

    Guido Lastra-Gonzalez, Camila Margarita Manrique, Gurushankar Govindarajan, Adam Whaley-Connell, James R Sowers. (2005) Insights into the emerging cardiometabolic prevention and management of diabetes mellitus. Expert Opinion on Pharmacotherapy 6:13, 2209-2221
    CrossRef

  111. 111

    H. Gohlke. (2005) Ernährung. Zeitschrift für Kardiologie 94:S3, iii15-iii21
    CrossRef

  112. 112

    Emily S. Loghmani. (2005) Nutrition therapy for overweight children and adolescents with Type 2 Diabetes. Current Diabetes Reports 5:5, 385-390
    CrossRef

  113. 113

    Tina Costacou. (2005) Evaluation of epidemiologic evidence on the role of nutrition in the development of diabetes and its complications. Current Diabetes Reports 5:5, 366-373
    CrossRef

  114. 114

    Gerald M. Reaven. (2005) THE INSULIN RESISTANCE SYNDROME: Definition and Dietary Approaches to Treatment. Annual Review of Nutrition 25:1, 391-406
    CrossRef

  115. 115

    M Shah, K Tierney, B Adams-Huet, A Boonyavarakul, K Jacob, C Quittner, WL Dinges, D Peterson, A Garg. (2005) The role of diet, exercise and smoking in dyslipidaemia in HIV-infected patients with lipodystrophy. HIV Medicine 6:4, 291-298
    CrossRef

  116. 116

    Charles S. Brennan. (2005) Dietary fibre, glycaemic response, and diabetes. Molecular Nutrition & Food Research 49:6, 560-570
    CrossRef

  117. 117

    Brian Patterson, Jenny Ekman. 2005. Why Fruits and Vegetables Are Good for Health. , 333-396.
    CrossRef

  118. 118

    Matthias B. Schulze, Frank B. Hu. (2005) PRIMARY PREVENTION OF DIABETES: What Can Be Done and How Much Can Be Prevented?. Annual Review of Public Health 26:1, 445-467
    CrossRef

  119. 119

    David L. Katz. (2005) COMPETING DIETARY CLAIMS FOR WEIGHT LOSS: Finding the Forest Through Truculent Trees. Annual Review of Public Health 26:1, 61-88
    CrossRef

  120. 120

    Allison M. Pritchett, John P. Foreyt, Douglas L. Mann. (2005) Treatment of the metabolic syndrome: The impact of lifestyle modification. Current Atherosclerosis Reports 7:2, 95-102
    CrossRef

  121. 121

    M. Abdelgadir, M. Abbas, A. Jarvi, M. Elbagir, M. Eltom, C. Berne. (2005) Glycaemic and insulin responses of six traditional Sudanese carbohydrate-rich meals in subjects with Type 2 diabetes mellitus. Diabetic Medicine 22:2, 213-217
    CrossRef

  122. 122

    Patricia M. Heacock, Steven R. Hertzler, Jennifer A. Williams, Bryan W. Wolf. (2005) Effects of a medical food containing an herbal α-glucosidase inhibitor on postprandial glycemia and insulinemia in healthy adults. Journal of the American Dietetic Association 105:1, 65-71
    CrossRef

  123. 123

    H. Maeda, R. Yamamoto, K. Hirao, O. Tochikubo. (2005) Effects of agar (kanten) diet on obese patients with impaired glucose tolerance and type 2 diabetes. Diabetes, Obesity and Metabolism 7:1, 40-46
    CrossRef

  124. 124

    Raquel Garcia, Marta Benet, Catalina Arnau, Erik Cobo. (2004) Efficiency of the cross-over design: an empirical estimation. Statistics in Medicine 23:24, 3773-3780
    CrossRef

  125. 125

    J.I. Mann, I. De Leeuw, K. Hermansen, B. Karamanos, B. Karlström, N. Katsilambros, G. Riccardi, A.A. Rivellese, S. Rizkalla, G. Slama, M. Toeller, M. Uusitupa, B. Vessby. (2004) Evidence-based nutritional approaches to the treatment and prevention of diabetes mellitus. Nutrition, Metabolism and Cardiovascular Diseases 14:6, 373-394
    CrossRef

  126. 126

    Kathie L. Hermayer. (2004) Treatment of lipids and type 2 diabetes. Current Cardiology Reports 6:6, 443-450
    CrossRef

  127. 127

    J. Mozota Duarte, R. Boldova Aguar, A. García Noain, P. Cía Gómez. (2004) Estrategias terapéuticas de las hiperlipidemias. Medidas alimentarias y de estilo de vida. Medicine - Programa de Formación Médica Continuada Acreditado 9:18, 1115-1121
    CrossRef

  128. 128

    David L. Katz. (2004) Lifestyle and dietary modification for prevention of heart failure. Medical Clinics of North America 88:5, 1295-1320
    CrossRef

  129. 129

    Friedrich Trepel. (2004) Ballaststoffe: Mehr als ein Diätmittel. Wiener Klinische Wochenschrift 116:15-16, 511-522
    CrossRef

  130. 130

    Adrian Vella, Michael Camilleri, Robert A Rizza. (2004) The gastrointestinal tract and glucose tolerance. Current Opinion in Clinical Nutrition and Metabolic Care 7:4, 479-484
    CrossRef

  131. 131

    (2004) Whole Grain Intake and Insulin Sensitivity: Evidence from Observational Studies. Nutrition Reviews 62:7, 286-291
    CrossRef

  132. 132

    M. Parillo, G. Riccardi. (2004) Diet composition and the risk of type 2 diabetes: epidemiological and clinical evidence. British Journal of Nutrition 92:01, 7
    CrossRef

  133. 133

    Rocio Aller, Daniel Antonio de Luis, Olatz Izaola, Fernando La Calle, Lourdes del Olmo, Luis Fernandez, Teresa Arranz, J.M.Gonzalez Hernandez. (2004) Effect of soluble fiber intake in lipid and glucose leves in healthy subjects: a randomized clinical trial. Diabetes Research and Clinical Practice 65:1, 7-11
    CrossRef

  134. 134

    M. Lyly, E. Soini, U. Rauramo, L. Lahteenmaki. (2004) Perceived role of fibre in a healthy diet among Finnish consumers. Journal of Human Nutrition and Dietetics 17:3, 231-239
    CrossRef

  135. 135

    Meesook Kim, Eul-Sang Kim, Mi-Hyoun Park, Sung-Joo Hwang, Yoonhwa Jeong. (2004) Saengshik , a Formulated Health Food, Decreases Blood Glucose and Increases Survival Rate in Streptozotocin-Induced Diabetic Rats. Journal of Medicinal Food 7:2, 162-167
    CrossRef

  136. 136

    Brigid McKevith. (2004) Nutritional aspects of cereals. Nutrition Bulletin 29:2, 111-142
    CrossRef

  137. 137

    Mark A Moyad, Peter R Carroll. (2004) Lifestyle recommendations to prevent prostate cancer, part II: time to redirect our attention?. Urologic Clinics of North America 31:2, 301-311
    CrossRef

  138. 138

    Clifford J. Bailey. 2004. New Drugs for the Treatment of Diabetes Mellitus. .
    CrossRef

  139. 139

    Mi??o ??abovi??, Simona Lavre, Irena Keber. (2004) Supplementation of wheat fibre can improve risk profile in patients with dysmetabolic cardiovascular syndrome. European Journal of Cardiovascular Prevention & Rehabilitation 11:2, 144-148
    CrossRef

  140. 140

    J.I. Mann, N.J. Lewis-Barned. 2004. Dietary Management of Diabetes Mellitus in Europe and North America. .
    CrossRef

  141. 141

    R. E. Wachters-Hagedoorn, M. G. Priebe, R. J. Vonk. 2004. Analysing starch digestion. , 575-589.
    CrossRef

  142. 142

    Jue Li, Takashi Kaneko, Li-Qiang Qin, Jing Wang, Yuan Wang. (2003) Effects of barley intake on glucose tolerance, lipid metabolism, and bowel function in women. Nutrition 19:11-12, 926-929
    CrossRef

  143. 143

    Jo Ann S. Carson. (2003) Nutrition therapy for dyslipidemia. Current Diabetes Reports 3:5, 397-403
    CrossRef

  144. 144

    Diana Gentilcore, Deirdre O'Donovan, Karen L. Jones, Michael Horowitz. (2003) Nutrition therapy for diabetic gastroparesis. Current Diabetes Reports 3:5, 418-426
    CrossRef

  145. 145

    Vladimir Vuksan, Augustine Marchie, Mark Stavro, Cyril Kendall, David Jenkins. 2003. Flaxseed, Fiber, and Coronary Heart Disease. .
    CrossRef

  146. 146

    Jue Li, Takashi Kaneko, Li-Qiang Qin, Jing Wang, Yuan Wang, Akio Sato. (2003) Long-term effects of high dietary fiber intake on glucose tolerance and lipid metabolism in GK rats: comparison among barley, rice, and cornstarch. Metabolism 52:9, 1206-1210
    CrossRef

  147. 147

    A. Gavrila, S. Tsiodras, J. Doweiko, G. Sonia Nagy, K. Brodovicz, W. Hsu, A. W. Karchmer, C. S. Mantzoros. (2003) Exercise and Vitamin E Intake Are Independently Associated with Metabolic Abnormalities in Human Immunodeficiency Virus--Positive Subjects: A Cross-Sectional Study. Clinical Infectious Diseases 36:12, 1593-1601
    CrossRef

  148. 148

    Joanne Slavin. (2003) Impact of the proposed definition of dietary fiber on nutrient databases. Journal of Food Composition and Analysis 16:3, 287-291
    CrossRef

  149. 149

    Jesica Pagano-Therrien, David L. Katz. (2003) The Low-Down on Low-Carbohydrate Diets. The Nurse Practitioner 28:3, 5-6
    CrossRef

  150. 150

    Tony Hung, John L. Sievenpiper, Augustine Marchie, Cyril W.C. Kendall, David J.A. Jenkins. (2003) Fat versus carbohydrate in insulin resistance, obesity, diabetes and cardiovascular disease. Current Opinion in Clinical Nutrition and Metabolic Care 6:2, 165-176
    CrossRef

  151. 151

    Maureen A. Murtaugh, David R. Jacobs, Brenda Jacob, Lyn M. Steffen, Leonard Marquart. (2003) Epidemiological support for the protection of whole grains against diabetes. Proceedings of the Nutrition Society 62:01, 143-149
    CrossRef

  152. 152

    James W. Anderson. (2003) Whole grains protect against atherosclerotic cardiovascular disease. Proceedings of the Nutrition Society 62:01, 135-142
    CrossRef

  153. 153

    Nicola Abate, Manisha Chandalia. (2003) The impact of ethnicity on type 2 diabetes. Journal of Diabetes and its Complications 17:1, 39-58
    CrossRef

  154. 154

    Rukmini Cheruvanky. 2003. Phytochemical products: rice bran. , 347-376.
    CrossRef

  155. 155

    Enzo Ragucci, Joel Zonszein, William H. Frishman. (2003) Pharmacotherapy of Diabetes Mellitus: Implications for the Prevention and Treatment of Cardiovascular Disease. Heart Disease 5:1, 18-33
    CrossRef

  156. 156

    Brenda M Davy, Christopher L Melby. (2003) The effect of fiber-rich carbohydrates on features of Syndrome X. Journal of the American Dietetic Association 103:1, 86-96
    CrossRef

  157. 157

    Hope Barkoukis, Karen M. Fiedler, Edith Lerner. (2002) A Combined High-Fiber, Low-Glycemic Index Diet Normalizes Glucose Tolerance and Reduces Hyperglycemia and Hyperinsulinemia in Adults with Hepatic Cirrhosis. Journal of the American Dietetic Association 102:10, 1503-1507
    CrossRef

  158. 158

    B.C. Tungland, D. Meyer. (2002) Nondigestible Oligo- and Polysaccharides (Dietary Fiber): Their Physiology and Role in Human Health and Food. Comprehensive Reviews in Food Science and Food Safety 1:3, 90-109
    CrossRef

  159. 159

    R. Giacco, G. Clemente, G. Riccardi. (2002) Dietary fibre in treatment of diabetes: myth or reality?. Digestive and Liver Disease 34, S140-S144
    CrossRef

  160. 160

    Judith A Marlett, Michael I McBurney, Joanne L Slavin. (2002) Position of the American Dietetic Association. Journal of the American Dietetic Association 102:7, 993-1000
    CrossRef

  161. 161

    Nilo B. Cater, Abhimanyu Garg. (2002) The effect of dietary intervention on serum lipid levels in type 2 diabetes mellitus. Current Diabetes Reports 2:3, 289-294
    CrossRef

  162. 162

    P. M. Kris-Etherton, A. E. Binkoski, G. Zhao, S. M. Coval, K. F. Clemmer, H. D. Hecker, H. Jacques, T. D. Etherton. (2002) Dietary fat: assessing the evidence in support of a moderate-fat diet; the benchmark based on lipoprotein metabolism. Proceedings of the Nutrition Society 61:02, 287-298
    CrossRef

  163. 163

    ARCHANA JAISWAL MCELIGOT, ELIZABETH A GILPIN, CHERYL L ROCK, VICKY NEWMAN, KATHRYN A HOLLENBACH, CYNTHIA A THOMSON, JOHN P PIERCE. (2002) High Dietary Fiber Consumption is Not Associated With Gastrointestinal Discomfort in a Diet Intervention Trial. Journal of the American Dietetic Association 102:4, 549-551
    CrossRef

  164. 164

    M. Horowitz, D. ODonovan, K. L. Jones, C. Feinle, C. K. Rayner, M. Samsom. (2002) Gastric emptying in diabetes: clinical significance and treatment. Diabetic Medicine 19:3, 177-194
    CrossRef

  165. 165

    Simin Liu, Julie E Buring, Howard D Sesso, Eric B Rimm, Walter C Willett, JoAnn E Manson. (2002) A prospective study of dietary fiber intake and risk of cardiovascular disease among women. Journal of the American College of Cardiology 39:1, 49-56
    CrossRef

  166. 166

    Thomas Sudhop, Klaus von Bergmann. (2002) Cholesterol Absorption Inhibitors for the Treatment of Hypercholesterolaemia. Drugs 62:16, 2333-2347
    CrossRef

  167. 167

    Jeannette M. Goguen, Lawrence A. Leiter. (2002) Lipids and Diabetes Mellitus: A Review of Therapeutic Options. Current Medical Research and Opinion 18:s1, s58-s74
    CrossRef

  168. 168

    W G Thompson. (2001) Early recognition and treatment of glucose abnormalities to prevent type 2 diabetes mellitus and coronary heart disease.. Mayo Clinic Proceedings 76:11, 1137-1143
    CrossRef

  169. 169

    Colleen Hadigan, Shafali Jeste, Ellen J. Anderson, Rita Tsay, Helen Cyr, Steven Grinspoon. (2001) Modifiable Dietary Habits and Their Relation to Metabolic Abnormalities in Men and Women with Human Immunodeficiency Virus Infection and Fat Redistribution. Clinical Infectious Diseases 33:5, 710-717
    CrossRef

  170. 170

    Simin Liu, JoAnn E. Manson. (2001) Dietary carbohydrates, physical inactivity, obesity, and the ‘metabolic syndrome’ as predictors of coronary heart disease. Current Opinion in Lipidology 12:4, 395-404
    CrossRef

  171. 171

    Jill A. Kanaley, Ruth S. Weinstock. (2001) Nonpharmacologic therapy in the treatment of insulin resistance. Current Opinion in Endocrinology & Diabetes 8:4, 219-225
    CrossRef

  172. 172

    Joseph Keenan, David Jacobs, Mark Pereira, Len Marquart, Joel Pins. 2001. Whole Grains, Cereal Fiber, and Chronic Diseases. , 481-497.
    CrossRef

  173. 173

    Kim Randles, Abayomi Akanji, James Anderson. 2001. Treatment of Diabetes with High-Fiber Diets. , 373-400.
    CrossRef

  174. 174

    Kenneth L. Koch. (2001) Electrogastrography: Physiological Basis and Clinical Application in Diabetic Gastropathy. Diabetes Technology & Therapeutics 3:1, 51-62
    CrossRef

  175. 175

    Michael Mcintosh, Carla Miller. (2001) A Diet Containing Food Rich in Soluble and Insoluble Fiber Improves Glycemic Control and Reduces Hyperlipidemia Among Patients with Type 2 Diabetes Mellitus. Nutrition Reviews 59:2, 52-55
    CrossRef

  176. 176

    James W. Anderson. (2000) Dietary fiber prevents carbohydrate-induced hypertriglyceridemia. Current Atherosclerosis Reports 2:6, 536-541
    CrossRef

  177. 177

    Mark A. Pereira, Joel J. Pins. (2000) Dietary fiber and cardiovascular disease: Experimental and epidemiologic advances. Current Atherosclerosis Reports 2:6, 494-502
    CrossRef

  178. 178

    Dennis A. Savaiano, Jon A. Story. (2000) Cardiovascular Disease and Fiber: Is Insulin Resistance the Missing Link?. Nutrition Reviews 58:11, 356-358
    CrossRef

  179. 179

    Gerald M. Reaven. (2000) Diet and syndrome X. Current Atherosclerosis Reports 2:6, 503-507
    CrossRef

  180. 180

    Nancy F. Sheard, Nathaniel G. Clark. (2000) The Role of Nutrition Therapy in the Management of Diabetes Mellitus. Nutrition in Clinical Care 3:6, 334-348
    CrossRef

  181. 181

    Rendell, Marc, . (2000) Dietary Treatment of Diabetes Mellitus. New England Journal of Medicine 342:19, 1440-1441
    Full Text